You are here: Start > Publications > PCN51 OUTCOMES MANAGEMENT IN A REAL WORLD EVIDENCE CONTEXT. THE CASE OF ABIRATERONE AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER > View related publications
Copyright 1996-2025 © Faculdade de Engenharia da Universidade do Porto
I Terms and Conditions
I Accessibility
I Index A-Z
I Guest Book
Page generated on: 2025-12-09 at 22:42:32 | Acceptable Use Policy | Data Protection Policy | Complaint Portal
Page generated on: 2025-12-09 at 22:42:32 | Acceptable Use Policy | Data Protection Policy | Complaint Portal